This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Apotea AB
Q22026
7/17/2026
Sara Ahlström
COO
Good morning everyone and welcome to the presentation of Apothea's second quarter report. As usual we will start with a presentation and after the presentation is done we will move on to a Q&A with spoken questions. Today's presenters are Per Svärdson, CEO and co-founder, Johan Morill, CFO and myself, Sara Ahlström, COO. And we will begin with some highlights of the quarterly figures.
Per Svärdson
CEO and Co-founder
Yeah, hello. I think we have had a good quarter with good profitability and stable growth. So Johan, please show us the figures.
Johan Morill
CFO
Yes, we had revenues of 2 billion and 26 million in the quarter and a growth of 10 points. 9%. We had a strong profitability in the quarter. We increased adjusted EBIT and had an adjusted EBIT margin of 5.2%.
You're reading a preview of the APOTEA.ST Q2 2026 earnings call.
Free account.
Disclaimer